APA (7th ed.) Citation

Liu, Z., Liu, Z., Long, G., Long, G., Zhang, Y., Zhang, Y., . . . Li, H. (2021). Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Liu, Zheng, et al. Thulium Laser Resection of Bladder Tumors Vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Liu, Zheng, et al. Thulium Laser Resection of Bladder Tumors Vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy. Frontiers Media S.A, 2021.